Ian A. Clark
Canberra, ACT, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease.
Journal: Pharmacology research & perspectives
Published: June 29, 2023
The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer's disease.
Journal: Molecular neurodegeneration
Published: January 11, 2023
Basic Scientific Evidence Consistent with Etanercept Efficacy Against Alzheimer's Disease.
Journal: Neuroscience
Published: February 14, 2022
Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic.
Journal: Pharmacology research & perspectives
Published: December 30, 2021
How diseases caused by parasites allowed a wider understanding of disease in general: my encounters with parasitology in Australia and elsewhere over the last 50 years.
Journal: International journal for parasitology
Published: May 29, 2021
Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.
Journal: Journal of Alzheimer's disease : JAD
Published: January 18, 2021
Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm.
Journal: Reviews in medical virology
Published: November 16, 2020
New virtual CaRMS: perspectives from residency programs.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Published: October 10, 2020
Randomized controlled trial validating the use of perispinal etanercept to reduce post-stroke disability has wide-ranging implications.
Journal: Expert review of neurotherapeutics
Published: February 08, 2020
Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia.
Journal: Neurobiology of disease
Published: July 30, 2019
Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective - a Commentary.
Journal: Expert review of neurotherapeutics
Published: May 17, 2019
Last Updated: 09/26/2026